Ho Carole

EDGAR CIK 0001724605

Denali Therapeutics Inc. - DNLI

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer
Chief Medical Officer
Direct Buys
0
$0
0 Shares
Direct Sells
5
($911,712)
-39,957 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/07/2025
01/08/2025
Sell
-2,907 @ $20.81
 ($60,495) 175,673 (-1.63%) Direct
01/06/2025
01/08/2025
Sell
-12,255 @ $20.22
 ($247,796) 178,580 (-6.42%) Direct
08/21/2024
10b5-1
08/22/2024
Sell
-20,005 @ $24.57
 ($491,571) 118,810 (-14.41%) Direct
08/20/2024
08/22/2024
Sell
-2,453 @ $23.79
 ($58,357) 138,815 (-1.74%) Direct
08/13/2024
08/15/2024
Sell
-2,337 @ $22.89
 ($53,494) 141,268 (-1.63%) Direct